OHR Pharmaceutical Inc.

Profile

Business Description

Ohr Pharmaceutical, Inc. (OHRP) is a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases. The company has completed two clinical trials with squalamine lactate ophthalmic solution, 0.2%, for the treatment of the wet form of age-related macular degeneration.  In addition, Ohr has a sustained-release micro-fabricated micro-particle ocular drug delivery platform technology.

Address:
800 Third Avenue
11th Floor
New York, NY 10022

Email:
info@ohrpharmaceutical.com

Telephone:
212-682-8452

Fax:
212-644-0544

Details

CEO:
Jason Slakter M.D.

Issue Type:
Common Stock

Auditors:
MaloneBailey LLP

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

Sub-Industry:
Biotechnology

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)